MYGN 10-Q: SEC filing
Myriad Genetics
Filed with the SEC on · accession 0001628280-26-071767
MYGN filed a 10-Q (quarterly report) with the SEC on Nov 6, 2026. Myriad Genetics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification. The stock moved -5.9% by the first close after the filing.
Summary of the filing
Myriad Genetics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification. The certification confirms the financial statements fairly present the company's financial condition and that disclosure controls and procedures are effective.
Key details
How MYGN stock reacted
Close before
$6.29
Nov 5, 2026
First close after
-5.88%
$5.92
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for MYGN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for MYGN?
Click hereFrequently asked questions
What did MYGN file with the SEC on Nov 6, 2026?
MYGN filed a 10-Q (SEC filing). Myriad Genetics filed its quarterly report on Form 10-Q for the period ended September 30, 2026, accompanied by the CEO's Sarbanes-Oxley Section 302 certification. The certification confirms the financial statements fairly present the company's financial condition and that disclosure controls and procedures are effective.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did MYGN stock react to this filing?
MYGN closed at $6.29 before the filing and $5.92 on Nov 6, 2026 (-5.88%).
Other MYGN SEC filings
- 8-K · Regulatory actionNov 5, 2026
- 8-K · DivestitureNov 4, 2026
- 8-K · DivestitureOct 20, 2026
- 8-K · Executive departureOct 9, 2026
- 8-K · Executive departureSep 16, 2026
- 10-Q · SEC filingJul 31, 2026
- 8-K · Guidance cutJul 30, 2026
- 8-K · Board changeJun 23, 2026
- 144 · Insider sale plannedJun 8, 2026
- 8-K · SEC filingJun 4, 2026
Get alerts when MYGN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days